UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
Fate Therapeutics, Inc.
(Name of Issuer)
Common Stock, par value $0.001 per share
(Title of Class of Securities)
31189P102
(CUSIP Number)
January 31, 2024
(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)
☒ Rule 13d-1(c)
☐ Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).





CUSIP No. 31189P102
13G
 

1
NAMES OF REPORTING PERSONS
 
 
Boxer Capital, LLC
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
   
(a)
   
(b)☒
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Delaware
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5
SOLE VOTING POWER
 
 
0
 
 
 
 
6
SHARED VOTING POWER
 
 
6,171,000
 
 
 
 
7
SOLE DISPOSITIVE POWER
 
 
0
 
 
 
 
8
SHARED DISPOSITIVE POWER
 
 
6,171,000
 
 
 
 
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
6,171,000
 
 
 
 
10
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
 
6.3%
 
 
 
 
12
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
OO
 
 
 
 




CUSIP No. 31189P102
13G
 

1
NAMES OF REPORTING PERSONS
 
 
Boxer Asser Management Inc.
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
   
(a)
   
(b)☒
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Bahamas
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5
SOLE VOTING POWER
 
 
0
 
 
 
 
6
SHARED VOTING POWER
 
 
6,171,000
 
 
 
 
7
SOLE DISPOSITIVE POWER
 
 
0
 
 
 
 
8
SHARED DISPOSITIVE POWER
 
 
6,171,000
 
 
 
 
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
6,171,000
 
 
 
 
10
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
 
6.3%
 
 
 
 
12
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
CO
 
 
 
 




CUSIP No. 31189P102
13G
 

1
NAMES OF REPORTING PERSONS
 
 
Joe Lewis
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
   
(a)
   
(b)☒
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
United Kingdom
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5
SOLE VOTING POWER
 
 
0
 
 
 
 
6
SHARED VOTING POWER
 
 
6,171,000
 
 
 
 
7
SOLE DISPOSITIVE POWER
 
 
0
 
 
 
 
8
SHARED DISPOSITIVE POWER
 
 
6,171,000
 
 
 
 
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
6,171,000
 
 
 
 
10
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
 
6.3%
 
 
 
 
12
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
IN
 
 
 
 




CUSIP No. 31189P102
13G
 

1
NAMES OF REPORTING PERSONS
 
 
MVA Investors, LLC
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
   
(a)
   
(b)☒
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
Delaware
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5
SOLE VOTING POWER
 
 
0
 
 
 
 
6
SHARED VOTING POWER
 
 
290,000
 
 
 
 
7
SOLE DISPOSITIVE POWER
 
 
0
 
 
 
 
8
SHARED DISPOSITIVE POWER
 
 
290,000
 
 
 
 
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
290,000
 
 
 
 
10
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
 
0.3%
 
 
 
 
12
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
CO
 
 
 
 




CUSIP No. 31189P102
13G
 

1
NAMES OF REPORTING PERSONS
 
 
Aaron I. Davis
 
 
 
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
   
(a)
   
(b)☒
 
 
3
SEC USE ONLY
 
 
 
 
 
 
 
4
CITIZENSHIP OR PLACE OF ORGANIZATION
 
 
United States of America
 
 
 
 
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
5
SOLE VOTING POWER
 
 
0
 
 
 
 
6
SHARED VOTING POWER
 
 
290,000
 
 
 
 
7
SOLE DISPOSITIVE POWER
 
 
0
 
 
 
 
8
SHARED DISPOSITIVE POWER
 
 
290,000
 
 
 
 
9
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
 
290,000
 
 
 
 
10
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
 
 
 
 
 
11
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
 
0.3%
 
 
 
 
12
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
 
 
IN
 
 
 
 





Item 1. (a)
Name of Issuer
   
  The name of the issuer is Fate Therapeutics, Inc. (the “Issuer”).
   
Item 1. (b) Address of Issuer’s Principal Executive Offices
   
  The Issuer’s principal executive offices are located at 12278 Scripps Summit Drive, San Diego, CA 92131.
   
Item 2. (a) Name of Person Filing
   
  This Schedule 13G is jointly filed by Boxer Capital, LLC (“Boxer Capital”), Boxer Asset Management Inc. (“Boxer Management”), Joe Lewis, MVA Investors, LLC (“MVA Investors”) and Aaron I. Davis (collectively, the “Reporting Persons”). Boxer Management is the managing member and majority owner of Boxer Capital. Joe Lewis is the sole indirect beneficial owner of and controls Boxer Management. MVA Investors is the independent, personal investment vehicle of certain employees of Boxer Capital. Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors.
   
Item 2. (b)
Address of Principal Business Office or, if None, Residence
   
 
The principal business address of Boxer Capital, MVA Investors and Aaron I. Davis is: 12860 El Camino Real, Suite 300, San Diego, CA 92130. The principal business address of Boxer Management and Joe Lewis is: Cay House, EP Taylor Drive N7776, Lyford Cay, New Providence, Bahamas.
   
 Item 2. (c)
Citizenship
   
  Boxer Capital and MVA Investors are limited liability companies organized under the laws of Delaware. Boxer Management is a corporation organized under the laws of the Bahamas. Joe Lewis is a citizen of the United Kingdom. Aaron I. Davis is a citizen of the United States of America.
   
Item 2. (d)
Title of Class of Securities
   
  Common Stock, $0.001 par value per share (“Common Stock”).
   
Item 2. (e)
CUSIP Number
   
 
The CUSIP number for the Common Stock is 31189P102.
   
Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:
   
 
Not Applicable.
   
Item 4.
Ownership
   
 
(a)
Amount beneficially owned:





 
Boxer Capital, Boxer Management and Joe Lewis beneficially own 6,171,000 shares of Common Stock. MVA Investors and Aaron I. Davis beneficially own 290,000 shares of Common Stock. The Reporting Persons beneficially own, in the aggregate, 6,461,000 shares of Common Stock.
 
 
(b)
Percent of class:
   
 
All percentages of beneficial ownership set forth herein are based on 98,601,966 shares of Common Stock reported outstanding on October 31, 2023 in the Quarterly Report on Form 10-Q filed by the Issuer with the Securities and Exchange Commission on November 8, 2023. The number of shares of Common Stock beneficially owned by the Reporting Persons in the aggregate represent 6.6% of the Issuer’s outstanding shares of Common Stock.
   
 
(c)
Number of shares as to which such person has:
   
   
(i) Sole power to vote or to direct the vote:
       
     
None of the Reporting Persons has sole power to vote or to direct the vote of any shares of Common Stock.
     
   
(ii) Shared power to vote or to direct the vote:
     
     
Boxer Capital, Boxer Management and Joe Lewis have shared power to vote or to direct the vote of 6,171,000 shares of Common Stock. MVA Investors and Aaron I. Davis have shared power to vote or to direct the vote of 290,000 shares of Common Stock.
       
   
(iii) Sole power to dispose or to direct the disposition of:
       
     
None of the Reporting Persons has sole power to dispose or to direct the disposition of any shares of Common Stock.
       
   
(iv) Shared power to dispose or to direct the disposition of:
       
      Boxer Capital, Boxer Management and Joe Lewis have shared power to dispose or to direct the disposition of 6,171,000 shares of Common Stock. MVA Investors and Aaron I. Davis have shared power to dispose or to direct the disposition of 290,000 shares of Common Stock.
       
Item 5.
Ownership of Five Percent or Less of a Class
   
 
Not Applicable.
   
Item 6.
Ownership of More than Five Percent on Behalf of Another Person
   
 
Other than as may result from indirect interests of investors in Boxer Capital and MVA Investors, no persons other than the Reporting Persons have the right to receive or the




 
power to direct the receipt of dividends, or proceeds of sale of the securities disclosed herein.
   
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company
   
 
Not Applicable.
   
Item 8.
Identification and Classification of Members of the Group
   
 
Not Applicable.
   
Item 9.
Notice of Dissolution of Group
   
 
Not Applicable.
   
Item 10.
Certification
   
 
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
   
Exhibits  
1





SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated:  February 12, 2024
 
 
BOXER CAPITAL, LLC
 
 
 
 
 
By:
/s/ Aaron I. Davis
 
 
 
Name:  
Aaron I. Davis
 
 
Title:
Authorized Signatory
 
 
 
 
BOXER ASSET MANAGEMENT INC.
 
 
 
 
 
By:
/s/ Paul Higgs
 
 
 
Name: Paul Higgs
 
 
Title:
Director
 
 
 
 
JOSEPH C. LEWIS
 
 
 
 
 
/s/ Joseph C. Lewis
 
  
Joseph C. Lewis, Individually
 
 
 
 
 
MVA INVESTORS, LLC
 
     
 
By:
/s/ Aaron I. Davis
 
   
Name:
Aaron I. Davis
   
Title:
Authorized Signatory
     
 
AARON I. DAVIS 
 
     
 
/s/ Aaron I. Davis
 
  
Aaron I. Davis, Individually
 





Exhibit 99.1

JOINT FILING AGREEMENT
PURSUANT TO RULE 13d-1(k)
 The undersigned acknowledge and agree that the foregoing statement on Schedule 13G in respect of the Common Stock of Fate Therapeutics, Inc. is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G may be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements.  The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained herein or therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.
EXECUTED February 12, 2024.

 
BOXER CAPITAL, LLC
 
 
 
 
 
By:
/s/ Aaron I. Davis
 
 
 
Name:  
Aaron I. Davis
 
 
Title:
Authorized Signatory
 
 
 
 
BOXER ASSET MANAGEMENT INC.
 
 
 
 
 
By:
/s/ Paul Higgs
 
 
 
Name: Paul Higgs
 
 
Title:
Director
 
 
 
 
JOSEPH C. LEWIS
 
 
 
 
 
/s/ Joseph C. Lewis
 
  
Joseph C. Lewis, Individually
 
 
 
 
 
MVA INVESTORS, LLC
 
     
 
By:
/s/ Aaron I. Davis
 
   
Name:
Aaron I. Davis
   
Title:
Authorized Signatory
     
 
AARON I. DAVIS 
 
     
 
/s/ Aaron I. Davis
 
  
Aaron I. Davis, Individually